These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 20171406

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F, Dixit V, Messa P, Martin P.
    Vaccine; 2012 Mar 16; 30(13):2295-300. PubMed ID: 22285268
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.
    Fabrizi F, Dixit V, Magnini M, Elli A, Martin P.
    Aliment Pharmacol Ther; 2006 Aug 01; 24(3):497-506. PubMed ID: 16886915
    [Abstract] [Full Text] [Related]

  • 6. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
    Fabrizi F, Dixit V, Messa P, Martin P.
    Aliment Pharmacol Ther; 2010 Sep 01; 32(6):756-62. PubMed ID: 20662784
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J, Carlisle E, Smieja M, Kim PT, Lee CH.
    Am J Kidney Dis; 2010 Oct 01; 56(4):713-9. PubMed ID: 20630640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M, Acar K, Sucak GT, Yamaç K, Haznedar R.
    Eur J Haematol; 2007 Oct 01; 79(4):292-6. PubMed ID: 17655695
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
    Fabrizi F, Ganeshan SV, Dixit V, Martin P.
    Aliment Pharmacol Ther; 2006 Sep 01; 24(5):789-96. PubMed ID: 16918882
    [Abstract] [Full Text] [Related]

  • 12. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
    Weinstein T, Chagnac A, Boaz M, Ori Y, Herman M, Zevin D, Schmilovitz-Weiss H, Gafter U.
    Nephron Clin Pract; 2004 Sep 01; 97(2):c67-72. PubMed ID: 15218332
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
    Fabrizi F, Dixit V, Messa P, Martin P.
    J Viral Hepat; 2011 Oct 01; 18(10):730-7. PubMed ID: 20819147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM, Gang S, Dabhi M, Kulkarni PS.
    J Nephrol; 2007 Oct 01; 20(5):596-601. PubMed ID: 17918146
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.